Last reviewed · How we verify
Depo-Medrone
Depo-Medrone is a Small molecule drug developed by Keele University. It is currently FDA-approved.
At a glance
| Generic name | Depo-Medrone |
|---|---|
| Sponsor | Keele University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia (PHASE2)
- Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma (PHASE3)
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia (PHASE2)
- MAGIC Ruxolitinib for aGVHD (PHASE2)
- Post-operative Methylprednisolone Taper Course for Orthopedic Surgery (PHASE4)
- Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure (NA)
- Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (PHASE2)
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Depo-Medrone CI brief — competitive landscape report
- Depo-Medrone updates RSS · CI watch RSS
- Keele University portfolio CI
Frequently asked questions about Depo-Medrone
What is Depo-Medrone?
Depo-Medrone is a Small molecule drug developed by Keele University.
Who makes Depo-Medrone?
Depo-Medrone is developed and marketed by Keele University (see full Keele University pipeline at /company/keele-university).
What development phase is Depo-Medrone in?
Depo-Medrone is FDA-approved (marketed).
Related
- Manufacturer: Keele University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing